Review decisions
Showing 90 results of 332 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01084
Product Type: Drug
Control Number: 249774
DIN(s): 02526794, 02526808, 02526816, 02526824
Manufacturer: Allergan Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-02-22
Decision / Authorization Date: 2022-04-22
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1687370834165
Product Type: Drug
Control Number: 263638
DIN(s): 02537117
Manufacturer: Advanced Accelerator Applications USA, Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-04-22
Issued / Original Publication Date: 2023-06-21
Decision / Authorization Date: 2023-04-05
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1689944674439
Product Type: Drug
Control Number: 262080
DIN(s): 02537818
Manufacturer: Avir Pharma Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-04-08
Issued / Original Publication Date: 2023-07-20
Decision / Authorization Date: 2023-05-12
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1687791867767
Product Type: Drug
Control Number: 262815
Manufacturer: Red Leaf Medical Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-03-25
Decision / Authorization Date: 2023-05-26
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1704300260963
Product Type: Drug
Control Number: 262740
DIN(s): 02541009
Manufacturer: AstraZeneca Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-03-24
Issued / Original Publication Date: 2024-01-03
Decision / Authorization Date: 2023-08-31
Updated Date: 2024-08-02
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1732290566153
Product Type: Drug
Control Number: 261973
Manufacturer: Orimed Pharma Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-03-02
Decision / Authorization Date: 2024-03-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS01080
Product Type: Drug
Control Number: 247727
DIN(s): 02524368, 02524376, 02524384, 02524392, 02524406
Manufacturer: Takeda Canada Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2020-12-18
Decision / Authorization Date: 2022-01-14
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1719939219034
Product Type: Drug
Control Number: 259953
DIN(s): 02543338
Manufacturer: Trimedic Therapeutics Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-12-30
Issued / Original Publication Date: 2024-07-02
Decision / Authorization Date: 2023-11-20
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD00628
Product Type: Drug
Control Number: 259397
DIN(s): 02533030
Manufacturer: Bristol-Myers Squibb Canada Co.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-12-08
Issued / Original Publication Date: 2023-03-10
Decision / Authorization Date: 2022-11-24
Updated Date: 2024-06-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1684173887386
Product Type: Drug
Control Number: 258772
DIN(s): 02532549, 02532557, 02532565, 02532573
Manufacturer: Bristol Myers Squibb Pharma
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2021-11-18
Issued / Original Publication Date: 2023-04-12
Decision / Authorization Date: 2022-11-08
Updated Date: 2023-04-12